Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy

Interactive Cardiovascular and Thoracic Surgery

Volumn 8, Issue 1, 2009, Pages 84-88

  Murray, Margaret A ^a   Osaki, Satoru ^a   Edwards, Niloo M ^a   Johnson, Maryl R ^a   Bobadilla, Joseph L ^a   Gordon, Elizabeth A ^a   Sanderfoot, Mark ^a   Kohmoto, Takushi ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Congestive heart failure; Mechanical circulatory support; Ventricular assist device

Indexed keywords

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE THERAPY; FEMALE; HEALTH CARE COST; HEART ASSIST DEVICE; HEART SURGERY; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT PLANNING;

ADULT; COST SAVINGS; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT DISCHARGE; PATIENT READMISSION; POSTOPERATIVE CARE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 58149391573     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.187377     Document Type: Conference Paper

References (15)

1. Schulman KA, Mark DB, Califf RM. Outcomes and costs within a disease management program for advanced congestive heart failure. Am Heart J 1998;135:S285-S292.
2. Wild D, Nawaz H, Chan W, Katz DL. Effects of interdisciplinary rounds on length of stay in a telemetry unit. J Public Health Manag Pract 2004;10:63-69.
3. McDonald K, Ledwidge M, Cahill J, Kelly J, Quigley P, Maurer B, Begley F, Ryder M, Travers B, Timmons C, Burke T. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge. Eur J Heart Fail 2001;3:209-215.
4. Harris LE, Luft FC, Rudy DW, Kesterson JG, Tierney WM. Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med 1998;105:464-471.
5. Young MP, Gooder VJ, Oltermann MH, Bohman CB, French TK, James BC. The impact of a multidisciplinary approach on caring for ventilator-dependent patients. Int J Qual Health Care 1998;10:15-26.
6. Morales DL, Catanese KA, Helman DN, Williams MR, Weinberg A, Goldstein DJ, Rose EA, Oz MC. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg 2000;119:251-259.
7. Gelijns AC, Richards AF, Williams DL, Oz MC, Oliveira J, Moskowitz AJ. Evolving costs of long-term left ventricular assist device implantation. Ann Thorac Surg 1997;64:1312-1319.
8. Evans RW. Costs and insurance coverage associated with permanent mechanical cardiac assistyreplacement devices in the United States. J Card Surg 2001;16:280-293.
9. Deng MC, Loebe M, El-Banayosy A, Gronda E, Jansen PG, Vigano M, Wieselthaler GM, Reichert B, Vitali E, Pavie A, Mesana T, Loisance DY, Wheeldon DR, Portner PM. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001;103:231-237.
10. Moskowitz AJ, Rose EA, Gelijns AC. The cost of long-term LVAD implantation. Ann Thorac Surg 2001;71:S195-S198.
11. Beyersdorf F. Economics of ventricular assist devices: European view. Ann Thorac Surg 2001;71:S192-S194.
12. Oz MC, Gelijns AC, Miller L, Wang C, Nickens P, Arons R, Aaronson K, Rickenbacker W, Van Meter C, Nelson K, Weinberg A. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg 2003;238:577-583.
13. Digiorgi P, Reel M, Thornton B, Naka Y, Oz MC. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 2005;24:200-204.
14. Portner PM. Economics of devices. Ann Thorac Surg 2001;71:S199-S201.
15. Morales DL, Argenziano M, Oz MC. Outpatient left ventricular assist device support: a safe and economical therapeutic option for heart failure. Prog Cardiovasc Dis 2000;43:55-66.